Geneva, Switzerland-based SGS Life Sciences has appointed Dr Katrien Lemmens as medical director for early phase clinical trials.
Dr Lemmens joins the contract solutions provider’s Antwerp, Belgium clinical pharmacology unit, and will lead the medical team there.
She brings experience as a clinical cardiologist to the role, and most recently served as associate professor of pathophysiology and pharmacology at the University of Antwerp.
Previously, Dr Lemmens was medical director of Janssen Pharmaceuticals’ clinical pharmacology unit in Meksem.
Jean-Luc Marsat, managing director at SGS Clinical Research, said: “Katrien joins SGS at an exciting time for the company.
“We look to strengthen our medical team with talents to match our strategy of ensuring our clients have access to best-in-class experts and services for their early phase patient clinical trials.
“Understanding increasingly complex clinical client’s needs and implementing solutions is what drives us as a company.”